SCHEMBL8714742

SCHEMBL8714742

CCCCN(CCC)C(=O)C1c2ccccc2-c2cccc(N3CCCC(NC(=O)c4ccccc4)C3)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ PPARD Q03181 2/20 0.38
▸ PPARA Q07869 2/20 0.38
▸ UTS2R Q9UKP6 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ CARM1 Q86X55 1/20 0.36
▸ PRMT6 Q96LA8 1/20 0.36
▸ USP30 Q70CQ3 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ DRD2 P14416 2/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35
▸ CCR2 P41597 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8669685 0.95 NPSR1 (0.42) NPSR1CHRM1UTS2RCARM1PRMT6
SCHEMBL8502237 0.92 NPSR1 (0.38) NPSR1CHRM1UTS2RHPGDDRD2
SCHEMBL8665880 0.87 UTS2R (0.39) NPSR1CHRM1UTS2RCARM1PRMT6
SCHEMBL8666092 0.84 UTS2R (0.39) NPSR1CHRM1UTS2RCARM1PRMT6
SCHEMBL8501233 0.83 NPSR1 (0.36) NPSR1CHRM1UTS2RHPGDDRD2
SCHEMBL8480927 0.82 NPSR1 (0.41) NPSR1HPGDGAADRD2HTR1A
SCHEMBL8485533 0.82 NPSR1 (0.42) NPSR1UTS2RCARM1PRMT6DRD2
SCHEMBL8480408 0.81 TMEM97 (0.38) NPSR1HPGDGAAHTR2AALDH1A1
SCHEMBL8501048 0.81 NPSR1 (0.35) NPSR1CHRM1UTS2RHPGDHTR2A
SCHEMBL8484454 0.79 NPSR1 (0.42) NPSR1UTS2RCARM1PRMT6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US disclosed
Send feedback